CVS Health (NYSE:CVS – Get Free Report)‘s stock had its 'overweight' rating reiterated by research analysts at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They currently have a $87.00 price objective on the pharmacy operator's stock. Cantor Fitzgerald's target price would indicate a potential upside of 24.32% from the […] The post CVS Health (NYSE:CVS) Receives Overweight Rating from Cantor Fitzgerald first appeared on Daily Political .

https://www.dailypolitical.com/2023/09/15/cvs-health-nysecvs-receives-overweight-rating-from-cantor-fitzgerald.html

#dailypolitical